Sentry Investments’s Allergan plc AGN Stock Holding History

Sentry Investments’s Portfolio AGN Stock Details AGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	$41.7M	Buy	247,800 +84,500	+52%	+$14.2M	0.62%	48
2017 Q4	$26.7M	Buy	+163,300	New	+$29.3M	0.34%	72
2017 Q1	–	Sell	-38,550	Closed	-$8.1M	–	166
2016 Q4	$8.1M	Sell	38,550 -2,900	-7%	-$601K	0.06%	112
2016 Q3	$9.55K	Buy	41,450 +100	+0.2%	+$24.4K	0.08%	108
2016 Q2	$9.56K	Sell	41,350 -9,000	-18%	-$2.08M	0.09%	100
2016 Q1	$13.5K	Sell	50,350 -7,500	-13%	-$2.15M	0.16%	86
2015 Q4	$18.1K	Sell	57,850 -13,850	-19%	-$4.12M	0.21%	87
2015 Q3	$19.5K	Buy	71,700 +200	+0.3%	+$61.4K	0.24%	83
2015 Q2	$21.7K	Buy	71,500 +31,000	+77%	+$9.25M	0.25%	83
2015 Q1	$12.1M	Buy	+40,500	New	+$11.5M	0.15%	109

Other funds holding AGN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return

Sentry Investments's AGN Position: Q1 2018 in Review

Sentry Investments increased its Allergan plc (AGN) stake by 52% in Q1 2018, buying an estimated $14.2M and bringing the position to 247,800 shares worth $41.7M. The position accounts for 0.62% of the portfolio, ranked #48.

Sentry Investments first reported a position in AGN in Q1 2015 and has held it in 10 quarters since. 1,022 funds tracked by Wall St. Rank hold AGN as of Q1 2018.

Sentry Investments held 247,800 shares of Allergan plc worth $41.7M as of Q1 2018.
Sentry Investments bought 84,500 Allergan plc shares in Q1 2018, an estimated $14.2M.
Allergan plc made up 0.62% of Sentry Investments's portfolio in Q1 2018, its #48 holding.
Sentry Investments first reported a position in Allergan plc in Q1 2015 and has held it in 10 quarters since.
1,022 funds tracked by Wall St. Rank held Allergan plc as of Q1 2018.

Based on Sentry Investments's 13F filing for Q1 2018, filed 11 May 2018.